Table 3.
Evaluation | Group | N | Average ± SD | CI 95% for the average | % change | P* |
---|---|---|---|---|---|---|
Before treatment | 10 mg | 35 | 6.8 ± 2.5 | 5.9–7.7 | – | 0.220 |
5 mg | 35 | 6.2 ± 1.7 | 5.5–7.0 | – | ||
3 months’ treatment | 10 mg | 35 | 9.2 ± 4.5 | 7.7–10.7 | 35.3% ↑ | 0.013 |
5 mg | 33 | 7.0 ± 2.7 | 5.6–7.2 | 12.9% ↑ | ||
6 months’ treatment | 10 mg | 35 | 11.5 ± 6.3 | 9.0–12.5 | 69.4% ↑ | 0.002 |
5 mg | 31 | 7.4 ± 2.6 | 6.5–8.1 | 19.4% ↑ | ||
9 months’ treatment | 10 mg | 35 | 10.8 ± 6.6 | 8.8–14.0 | 58.8% ↑ | 0.013 |
5 mg | 31 | 7.6 ± 3.2 | 6.4–8.4 | 22.6% ↑ |
Note: *t-test.
Abbreviations: CI, confidence interval; SD, standard deviation.